dapagliflozin
astrazeneca
['dapagliflozin']
#esccongress | deliver results were irrespective of ef (even higher) and care setting adverse events were similar to placebo dapagliflozin was as effective among patients with improved ef to over 40%, a group who had been excluded from all prior trials 
Latest research in cardiology | Breaking news, insights, interviews, live tweeting and updates from major conferences. Co-published by @ilpensiero | @think2it